Hypertension Journal

Register      Login

VOLUME 2 , ISSUE 1 ( January-March, 2016 ) > List of Articles

RESEARCH ARTICLE

Management of Hypertension in Patients with Cardiovascular Disease

K Venugopal, Z Sajan Ahmad

Keywords : Acute coronary syndrome,Heart failure,Hypertension,Stable ischemic heart disease

Citation Information : Venugopal K, Ahmad ZS. Management of Hypertension in Patients with Cardiovascular Disease. Hypertens J 2016; 2 (1):10-15.

DOI: 10.5005/jp-journals-10043-0023

Published Online: 00-03-2016

Copyright Statement:  Copyright © 2016; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

How to cite this article

Venugopal K, Ahmad ZS. Management of Hypertension in Patients with Cardiovascular Disease. Hypertens J 2016;2(1):10-15


PDF Share
  1. Reducing the global burden of blood pressure-related cardiovascular disease. J Hypertens Suppl 2000 May;18(1):S3-S6.
  2. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004 Sep 11-17;364(9438):937-952.
  3. Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J Hypertens 2014 Jun;32(6):1170-1177.
  4. Trends in hypertension epidemiology in India. J Hum Hypertens 2004 Feb;18(2):73-78.
  5. 2013 ACC/AHA guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. Circulation 2014;129:S1-S45.
  6. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-153.
  7. European trial on reduction of cardiac events with perindopril in stable coronary artery disease investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003 Sep 6;362(9386):782-788.
  8. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; Trans Atlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006 Mar 21;113(11):e463–e654.
  9. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002 Dec 18;288(23):2981-2997.
  10. Treatment of hypertension in patients with coronary artery disease. A scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. J Am Coll Cardiol 2015;65(18):1998-2038.
  11. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013;127:529-555.
  12. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for The Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction). Circulation 2007;116:803-877.
  13. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary. A report of the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation 2004;110:588-636.
  14. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002 Dec 14;360(9349):1903-1913.
  15. Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension: the studying the treatment of acute hypertension (STAT) registry. Am Heart J 2009 Oct;158(4):599-606.
  16. Lancet 1999 Jun 12;353(9169): 2001-2007.
  17. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) Study. Circulation 2002 Oct 22;106(17):2194-2199.
  18. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005 Feb;26(3):215-225.
  19. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Lancet 1993 Oct;342(8875):821-828.
  20. Hypertension: a companion to Braunwald's heart disease. 2ed. Philadelphia: Saunders; 2007.
  21. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med 1995 Dec 21;333(25):1670-1676.
  22. SPRINT Research Group: A randomized trial of intensive versus standard blood-pressure control. N Eng J Med 2015 Nov 26;373(22):2103-2116.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.